Search results for "CG"

showing 10 items of 999 documents

Possible Role of Butyrylcholinesterase in Fat Loss and Decreases in Inflammatory Levels in Patients with Multiple Sclerosis after Treatment with Epig…

2021

(1) Background. Multiple sclerosis (MS) is characterised by the loss of muscle throughout the course of the disease, which in many cases is accompanied by obesity and related to inflammation. Nonetheless, consuming epigallocatechin gallate (EGCG) and ketone bodies (especially β-hydroxybutyrate (βHB)) produced after metabolising coconut oil, have exhibited anti-inflammatory effects and a decrease in body fat. In addition, butyrylcholinesterase (BuChE), seems to be related to the pathogenesis of the disease associated with inflammation, and serum concentrations have been related to lipid metabolism. Objective. The aim of the study was to determine the role of BuChE in the changes caused after…

AdultMalemedicine.medical_specialtyfood.ingredientPilot ProjectsEpigallocatechin gallatemultiple sclerosisAntioxidantsCatechinArticlechemistry.chemical_compoundfoodβ-hydroxybutyrateInternal medicineWeight LossmedicineHumansTX341-641ObesityButyrylcholinesteraseNutrition and DieteticsbiologyNutrition. Foods and food supplybusiness.industryCoconut oilParaoxonaseAlbuminMiddle AgedLipid Metabolismmedicine.diseaseObesityPON1EndocrinologyAdipose TissuechemistryinflammationDietary SupplementsbutyrylcholinesteraseCoconut Oilbiology.proteinKetone bodiesFemalebusinessEGCGFood ScienceNutrients
researchProduct

The clinical value of PSA increase during intravesical adjuvant therapy for nonmuscle-invasive bladder cancer.

2016

Introduction Prostatic Specific Antigen (PSA), Bacillus Calmette-Guerin (BCG) increase after intravesical BCG has been reported. The need of prostate biopsy in these patients is object of debate. The aim of our study was to evaluate the effect of intravesical therapy on PSA after transurethral resection (TUR) of nonmuscle-invasive bladder cancer (NMIBC). Materials and methods Patients undergoing intravesical chemotherapy or immunotherapy for NMIBC were entered. PSA was measured before TUR, before the first and after the sixth instillation, 30 and 90 days after the last instillation. Patients with PSA ≥4 ng/ml or palpable prostate nodule were excluded. Results Out of 130 patients, 105 were e…

Adultmedicine.medical_specialtyProstate biopsymedicine.medical_treatment030232 urology & nephrologyUrologyAntineoplastic Agents03 medical and health sciencesProstate cancer0302 clinical medicineAdjuvants ImmunologicBiopsyIntravesical instillation Prostate cancer PSAmedicineAdjuvant therapyCombined Modality TherapyHumansNeoplasm InvasivenessAgedAged 80 and overChemotherapyBladder cancermedicine.diagnostic_testbusiness.industryGeneral MedicineImmunotherapyMiddle AgedProstate-Specific Antigenmedicine.diseaseCombined Modality TherapyAdministration IntravesicalUrinary Bladder Neoplasms030220 oncology & carcinogenesisBCG VaccinebusinessUrologia
researchProduct

Expression and distribution of key enzymes of the cyclic GMP signaling in the human clitoris: relation to phosphodiesterase type 5 (PDE5)

2011

The clitoris contributes to the normal female sexual response cycle. A significance of cyclic guanosine monophosphate (GMP) has been assumed in the control of clitoral vascular smooth muscle. As only a few investigations on the physiology of the vascular and non-vascular clitoral tissue have been carried out, knowledge on the mechanisms controlling this particular female genital organ is still vague. It has been suggested that human clitoral corpus cavernosum smooth muscle is regulated by nitric oxide (NO)/cyclic GMP and related key enzymes, such as NO synthases (NOSs) and the phosphodiesterase type 5 (PDE5). The present study evaluated in the human clitoris, by means of immunohistochemistr…

Adultmedicine.medical_specialtyVascular smooth muscleStromal cellAdolescentNitric Oxide Synthase Type IIIUrologyClitorisBiologyEndothelial NOSSecond Messenger SystemsClitorisNitric oxideYoung Adultchemistry.chemical_compoundInternal medicineCyclic GMP-Dependent Protein KinasesmedicineHumansVimentinProtein kinase ACyclic GMPCyclic guanosine monophosphateCyclic Nucleotide Phosphodiesterases Type 5Cyclic Nucleotide Phosphodiesterases Type 2Immunohistochemistrymedicine.anatomical_structureEndocrinologychemistrycGMP-specific phosphodiesterase type 5FemaleInternational Journal of Impotence Research
researchProduct

Abstract WP201: Stroke Patients With Atrial Fibrillation Detected by 72 hour- versus Prolonged ECG-monitoring

2018

Background: Detecting concealed paroxysmal atrial fibrillation (pAF) is a major focus in the workup of ischemic-stroke-patients. The minimal ECG-monitoring for stroke patients was recently expanded from 24 to 72 hours. However, it has been shown that even more prolonged monitoring reveals further pAF-cases. Our aim was to determine, whether known predictors for underlying pAF differ between stroke patients with AF that occurs on shorter (72h) or more prolonged ECG-monitoring (>72h). Methods: The Find-AF RANDOMISED -trial (NCT01855035) evaluated 3x10-day Holter-ECG vs. standard-care in patients > 60 years with acute ischemic strokes with the primary endpoint of novel pAF after 6 month…

Advanced and Specialized Nursingmedicine.medical_specialtyStroke patientmedicine.diagnostic_testbusiness.industrymedicine.drug_classParoxysmal atrial fibrillationAtrial fibrillation030204 cardiovascular system & hematologymedicine.diseaseEcg monitoring03 medical and health sciences0302 clinical medicineInternal medicinemedicineNatriuretic peptideCardiologycardiovascular diseasesNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessElectrocardiographyStroke030217 neurology & neurosurgeryStroke
researchProduct

Abstract 124: How to Preselect Stroke Patients for Enhanced ECG-Monitoring - Evaluation of Predictors of Paroxysmal Atrial Fibrillation in "Find-AFra…

2019

Background: Detecting concealed paroxysmal atrial fibrillation (pAF) is a major focus of the workup of ischemic-stroke-patients, but requires elaborate ECG-monitoring. We aimed to evaluate pre-specified predictors to determine stroke patients with an increased probability of underlying pAF. We applied cut-off-levels recently suggested by the German Stroke Society 1 . Methods: The Find-AF RANDOMISED -trial (NCT01855035) evaluated 3x10-day Holter-ECG vs. standard-care in 398 patients > 60 years with acute ischemic strokes. The primary endpoint was novel pAF after 6 months. 27 patients in the intervention arm (13.5 %) and 9 patients in the control arm (9.0 %) met the primary endpoint (p=0.…

Advanced and Specialized Nursingmedicine.medical_specialtymedicine.diagnostic_testStroke patientParoxysmal atrial fibrillationbusiness.industryAtrial fibrillation030204 cardiovascular system & hematologymedicine.diseaseEcg monitoring03 medical and health sciences0302 clinical medicineInternal medicinemedicineCardiologycardiovascular diseasesNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessElectrocardiography030217 neurology & neurosurgeryStroke
researchProduct

Electrocardiographic Diagnosis of Atrial Tachycardia: Classification, P-Wave Morphology, and Differential Diagnosis with Other Supraventricular Tachy…

2015

Atrial tachycardia is defined as a regular atrial activation from atrial areas with centrifugal spread, caused by enhanced automaticity, triggered activity or microreentry. New ECG classification differentiates between focal and macroreentrant atrial tachycardia. Macroreentrant atrial tachycardias include typical atrial flutter and other well characterized macroreentrant circuits in right and left atrium. Typical atrial flutter has been described as counterclockwise reentry within right atrial and it presents a characteristic ECG “sawtooth” pattern on the inferior leads. The foci responsible for focal atrial tachycardia do not occur randomly throughout the atria but tend to cluster at chara…

Aged 80 and overMaleSettore MED/09 - Medicina InternaHeart Rate FetalDiagnosis DifferentialElectrocardiographyPrenatal Diagnosiscardiovascular systemTachycardia SupraventricularHumansFemalecardiovascular diseasesReview ArticlesAtrial tachycardia ECGAged
researchProduct

Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help.

2007

Liver or lung metastases usually relapse under chemotherapy. Such life-threatening condition urgently needs new, systemic anticancer compounds, with original and efficient mechanisms of action. In B16 melanoma mice treated with cyclophosphamide, D'Agostini et al. [D'Agostini, C., Pica, F., Febbraro, G., Grelli, S., Chiavaroli, C., Garaci, E., 2005. Antitumour effect of OM-174 and Cyclophosphamide on murine B16 melanoma in different experimental conditions. Int. Immunopharmacol. 5, 1205-1212.] recently found that OM-174, a chemically defined Toll-like receptor(TLR)2/4 agonist, reduces tumor progression and prolongs survival. Here we review 149 articles concerning molecular mechanisms of TLR2…

AgonistLipopolysaccharidesCyclophosphamidemedicine.drug_classmedicine.medical_treatmentNitric Oxide Synthase Type IIAntineoplastic AgentsApoptosisNitric oxidechemistry.chemical_compoundRecurrenceNeoplasmsMedicineAnimalsHumansPharmacologyChemotherapybusiness.industryTumor Necrosis Factor-alphaCancerDendritic Cellsmedicine.diseaseNeoadjuvant TherapyToll-Like Receptor 2Interleukin-10Toll-Like Receptor 4TLR2Lipid ATreatment OutcomechemistryTumor progressionChemotherapy AdjuvantDrug Resistance NeoplasmEnzyme InductionImmunologyCancer researchBCG VaccineTumor necrosis factor alphaImmunotherapybusinessmedicine.drugSignal TransductionT-Lymphocytes CytotoxicEuropean journal of pharmacology
researchProduct

Ontogenetic and Pharmacological Studies on Metabotropic Glutamate Receptors Coupled to Phospholipase D Activation

1997

The present study was aimed at characterizing the metabotropic receptor subtype which is involved in the activation of phospholipase D (PLD) by glutamate in rat hippocampal slices. We first observed that the ontogenetic profile of glutamate-induced hydrolysis of phosphoinositides and of phosphatidylcholine was strikingly similar. Both pathways were significantly activated by glutamate in tissue taken from 3-, 8- and 15-day old rats, but not in adult rats. PLD activation was strongest in slices taken from 8-day old rats. At this age, quisqualate had a higher potency for PLD activation (EC50: 0.6 microM) than 1S,3R-ACPD (EC50: 16 microM) and DHPG, a specific activator of group I mGluR, was a …

Agonistmedicine.medical_specialtymedicine.drug_classBiologyReceptors Metabotropic GlutamateHippocampusCellular and Molecular Neurosciencechemistry.chemical_compoundDCG-IVInternal medicinePhospholipase DmedicineAnimalsRats WistarPharmacologyDose-Response Relationship DrugMetabotropic glutamate receptor 5Glutamate receptorQuisqualic AcidRatsMetabotropic receptorEndocrinologychemistryMetabotropic glutamate receptorACPDMetabotropic glutamate receptor 1lipids (amino acids peptides and proteins)Neuropharmacology
researchProduct

Late Cretaceous continental weathering evolution on the southern Atlantic margins of Africa and South America : contributions of a new geochemical tr…

2022

The late Cretaceous records a pronounced decrease in temperatures on a global scale between 90 and 65 million years that marks the first step of the progressive climatic decline ultimately leading to our modern climate mode. This first cooling step is concomitant to a major tectonic uplift of the east South American and west African margins. Relief formation on the African ans South American continent, enhancing continental weathering, can have induced a climatic cooling at a global scale through atmospheric CO2 consumption linked to silicate weathering reactions. The main objective of this project is to explore the potentially determinant impact of this tectonic uplift on the long-term coo…

Altération continentalePaléoclimat[SDE.MCG] Environmental Sciences/Global ChangesMinéralogie des argilesPaleoclimateContinental weatheringGéochimie isotopiqueClay mineralogyCretaceousIsotopic geochemistryCrétacé supérieur
researchProduct

Distribution of clay minerals in Early Jurassic Peritethyan seas: palaeoclimatic significance inferred from multiproxy comparisons.

2009

13 pages; International audience; A set of published, unpublished, and new clay mineral data from 60 European and Mediterranean localities allows us to test the reliability of clay minerals as palaeoclimatic proxies for the Pliensbachian–Toarcian period (Early Jurassic) by reconstructing spatial and temporal variations of detrital fluxes at the ammonite biochronozone resolution. In order to discuss their palaeoclimatic meaning, a compilation of low-latitude belemnite δ18O, δ13C, Mg/Ca, and 87Sr/86Sr values is presented for the first time for the whole Pliensbachian– Toarcian period. Once diagenetic and authigenic biases have been identified and ruled out, kaolinite content variation is cons…

AmmoniteMediterranean climatePaleontologyPliensbachianAuthigenicToarcianOceanographyPalaeoclimate[ SDU.STU.ST ] Sciences of the Universe [physics]/Earth Sciences/Stratigraphy[ SDU.STU.GC ] Sciences of the Universe [physics]/Earth Sciences/Geochemistrylanguage.human_languageDiagenesisClay mineralsPaleontology[ SDE.MCG ] Environmental Sciences/Global ChangesPaleoclimatologylanguageKaoliniteSpatial variability[ SDU.STU.CL ] Sciences of the Universe [physics]/Earth Sciences/ClimatologyClay mineralsEcology Evolution Behavior and SystematicsGeologyEarth-Surface Processes
researchProduct